Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Optimi Health Corp (OP: OPTHF ) 0.2329 +0.0201 (+9.45%) Streaming Delayed Price Updated: 2:03 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Optimi Health Corp Optimi Health Announces C$3.27 Million Private Placement with Strategic Investment from Lululemon Founder Chip Wilson October 12, 2022 Optimi Health Corp. (CSE:OPTI) (OTCQX:OPTHF) is a Canadian-based company licensed by Health Canada to produce and supply natural, EU-GMP-grade psilocybin, synthetic psychedelic substances and... Via PressReach Psychedelic Drugs Prove Their Worth In Clinical Trials October 11, 2022 Novel psychedelic drugs have continuously proven their worth in clinical trials. Just recently, one company revealed that it was in the process of finalizing its Phase 1 first-in-human clinical trial... Via PressReach Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer’s Disease October 05, 2022 A Toronto-based biotech firm is developing a new psychedelic medicine to cure Alzheimer’s disease, announcing recently that it has gotten approval from Argentina’s regulators to begin a Phase ll... Via PressReach Topics Cannabis Exposures Cannabis Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer’s Disease October 05, 2022 FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – October 5, 2022 – A Toronto-based biotech firm is developing a new psychedelic medicine to cure Alzheimer’s disease,... Via FinancialNewsMedia Topics Cannabis Exposures Cannabis Optimi Health and ATMA Journey Centers to Send a Clinical Trial Application to Health Canada for Phase I Natural Psilocybin and MDMA September 22, 2022 Optimi Health Corp. (CSE:OPTI) (OTCQX:OPTHF) is a Canadian company that makes natural, scalable, and easy-to-get psychedelic and functional mushrooms, as well as synthetic formulations, to help people... Via PressReach Topics Supply Chain Exposures Supply Chain Psychedelics May Make People Less Afraid of Death September 07, 2022 FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 7, 2022 – According to a new survey by Johns Hopkins Medicine researchers, people’s attitudes toward death change... Via FinancialNewsMedia Topics Supply Chain Exposures Supply Chain Psychedelics Use Among Young Adults Reaches All-Time High September 01, 2022 FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 1, 2022 – Young adults are using more hallucinogens than ever. According to a National Institute of Health survey,... Via FinancialNewsMedia Toronto Addiction Center Gets First-Ever Federal Grant to Study Effects of Magic Mushroom on Depression August 10, 2022 FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – August 10, 2022 – Toronto’s Center for Addiction and Mental Health (CAMH) just received the first-ever federal grant to study... Via FinancialNewsMedia Topics Supply Chain Exposures Supply Chain Why North America Region is Dominating the Billion Dollar Psychedelic Drugs Market October 05, 2021 Palm Beach, FL – October 5, 2021 – FinancialNewsMedia.com News Commentary – The psychedelic drugs market is creating major potential for treatment of mental illnesses, and as a result, it is likely to... Via FinancialNewsMedia Optimi Health Natural Psilocybin Extraction Breakthrough Submitted for Provisional Patent Application October 05, 2021 Company utilizes green chemistry to stabilize natural product with higher yields Vancouver, BC – October 5, 2021 – Optimi Health Corp. (OTCQB: OPTHF) (CSE: OPTI) (FRA: 8BN) (“Optimi” or the “Company”),... Via FinancialNewsMedia Topics Intellectual Property Exposures Intellectual Property Rising Prevalence of Mental Depression & Anxiety Major Drivers Propelling Demand In Psychedelic Drugs Market July 07, 2021 Via FinancialNewsMedia Optimi Health Initiates Pathway to Nasdaq Listing July 07, 2021 Via FinancialNewsMedia Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.